Trial Profile
A Study to Identify Predictors of Response to Duloxetine in Breast Cancer Patients With Chronic Pain
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Aug 2020
Price :
$35
*
At a glance
- Drugs Duloxetine (Primary)
- Indications Pain
- Focus Therapeutic Use
- 18 May 2020 Status changed from recruiting to completed.
- 15 Jan 2019 Planned primary completion date changed from 1 Mar 2019 to 1 Mar 2022.
- 31 Aug 2017 Status changed from active, no longer recruiting to recruiting.